slotkoers
Shanghai S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
21,2
CNY
|
-0,84%
|
|
+0,66%
|
+13,98%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
13.614
|
12.508
|
13.948
|
18.276
|
18.992
|
21.645
|
-
|
-
|
Bedrijfswaarde
1 |
11.835
|
10.105
|
13.948
|
18.276
|
18.992
|
21.645
|
21.645
|
21.645
|
K/w-verhouding
|
12,9
x
|
12,4
x
|
14,9
x
|
15,9
x
|
14,3
x
|
14,5
x
|
12,8
x
|
11,8
x
|
Dividendrendement
|
2,33%
|
2,42%
|
-
|
-
|
1,38%
|
1,42%
|
1,6%
|
-
|
Marktkapitalisatie/omzet
|
1,45
x
|
1,47
x
|
1,53
x
|
1,93
x
|
1,86
x
|
1,9
x
|
1,7
x
|
1,65
x
|
Bedrijfswaarde/omzet
|
1,45
x
|
1,47
x
|
1,53
x
|
1,93
x
|
1,86
x
|
1,9
x
|
1,7
x
|
1,65
x
|
Bedrijfswaarde/EBITDA
|
8,39
x
|
7,8
x
|
8,8
x
|
9,48
x
|
8,86
x
|
9,33
x
|
8,38
x
|
8,05
x
|
Bedrijfswaarde/FCF
|
11.339.571
x
|
11.859.366
x
|
-
|
-
|
18.451.781
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
1,58
x
|
1,35
x
|
1,41
x
|
1,86
x
|
1,74
x
|
1,78
x
|
1,6
x
|
1,45
x
|
Aantal aandelen (in duizenden)
|
1.043.238
|
1.043.238
|
1.043.238
|
1.021.567
|
1.021.061
|
1.020.978
|
-
|
-
|
Referentieprijs
2 |
13,05
|
11,99
|
13,37
|
17,89
|
18,60
|
21,20
|
21,20
|
21,20
|
Datum van publicatie
|
20/03/20
|
18/03/21
|
24/03/22
|
27/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
9.381
|
8.504
|
9.112
|
9.447
|
10.222
|
11.390
|
12.724
|
13.089
|
EBITDA
1 |
1.623
|
1.605
|
1.585
|
1.928
|
2.142
|
2.320
|
2.583
|
2.690
|
Bedrijfsresultaat (EBIT)
1 |
1.262
|
1.229
|
1.137
|
1.406
|
1.515
|
1.780
|
2.009
|
2.182
|
Operationele Marge
|
13,46%
|
14,46%
|
12,48%
|
14,88%
|
14,82%
|
15,62%
|
15,79%
|
16,67%
|
Resultaat voor belastingen (EBT)
1 |
1.262
|
1.215
|
1.121
|
1.415
|
1.567
|
1.788
|
2.018
|
2.192
|
Nettowinst (verlies)
1 |
1.055
|
1.005
|
935,7
|
1.164
|
1.333
|
1.520
|
1.716
|
1.864
|
Nettomarge
|
11,25%
|
11,82%
|
10,27%
|
12,32%
|
13,04%
|
13,34%
|
13,49%
|
14,24%
|
WPA
2 |
1,011
|
0,9635
|
0,8969
|
1,124
|
1,300
|
1,463
|
1,650
|
1,795
|
Free Cash Flow
|
1.201
|
1.055
|
-
|
-
|
1.029
|
-
|
-
|
-
|
FCF-marge
|
12,8%
|
12,4%
|
-
|
-
|
10,07%
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
73,96%
|
65,73%
|
-
|
-
|
48,04%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
113,79%
|
104,93%
|
-
|
-
|
77,21%
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,3040
|
0,2900
|
-
|
-
|
0,2570
|
0,3000
|
0,3400
|
-
|
Datum van publicatie
|
20/03/20
|
18/03/21
|
24/03/22
|
27/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2024 Q1
|
---|
Omzet
1 |
2.835
|
EBITDA
|
-
|
Bedrijfsresultaat (EBIT)
|
-
|
Operationele Marge
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
Nettowinst (verlies)
1 |
416,1
|
Nettomarge
|
14,68%
|
WPA
|
-
|
Dividend per aandeel
|
-
|
Datum van publicatie
|
25/04/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
1.779
|
2.404
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
1.201
|
1.055
|
-
|
-
|
1.029
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
12,9%
|
11,3%
|
9,78%
|
11,7%
|
12,4%
|
12,3%
|
12,5%
|
11,9%
|
ROA (netto-inkomsten/totale activa)
|
9,78%
|
8,49%
|
-
|
-
|
8,71%
|
9,3%
|
9,55%
|
9,5%
|
Totale activa
1 |
10.792
|
11.846
|
-
|
-
|
15.298
|
16.344
|
17.969
|
19.621
|
Nettoactief per aandeel
2 |
8,250
|
8,910
|
9,490
|
9,610
|
10,70
|
11,90
|
13,30
|
14,70
|
Cashflow per aandeel
2 |
1,380
|
1,300
|
1,290
|
1,290
|
1,570
|
1,870
|
2,140
|
2,330
|
Capex
1 |
239
|
305
|
480
|
522
|
602
|
707
|
802
|
656
|
Capex/omzet
|
2,55%
|
3,59%
|
5,27%
|
5,52%
|
5,88%
|
6,21%
|
6,3%
|
5,01%
|
Datum van publicatie
|
20/03/20
|
18/03/21
|
24/03/22
|
27/03/23
|
21/03/24
|
-
|
-
|
-
|
Laatste slotkoers
21,2
CNY Gemiddelde koersdoel
24,91
CNY Spread / Gemiddelde doel +17,52% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +13,98% | 2,99 mld. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|